Anaphylaxis Treatment Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What combination of drivers is leading to accelerated growth in the anaphylaxis treatment market?
The increase in food allergy incidences is anticipated to stimulate the expansion of the anaphylaxis treatment market in the future. A food allergy is defined as an immune response to proteins present in food. Anaphylaxis treatment aids in halting the advancement of severe allergic symptoms, which can include skin and mucosal surface involvement, respiratory compromise, hypotension, and end-organ dysfunction. For instance, per the US Centers for Disease Control and Prevention in January 2023, in 2021, 31.8% of adults aged 18 and older indicated they had eczema, a seasonal allergy, or a food allergy. Seasonal allergies were reported by a quarter (25.7%) of adults, 6.2% reported a food allergy, and 7.3% had eczema. Moreover, the Food Standards Agency, a UK non-ministerial department, reported in August 2024 that from October 2021 to August 27, 2023, a total of 296 valid case reports were submitted to the Registry, representing less than 5% of accidental reactions in the UK. Of these, 213 (72%) were linked to food triggers and 208 (97.7%) were found in children and adolescents aged 18 or younger. Only 28 clinics and 11 Accident & Emergency departments registered for access to the platform. Consequentially, an increase in food allergies is fostering the growth of the anaphylaxis treatment market.

Get Your Anaphylaxis Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

What is the projected compound annual growth rate (CAGR) of the anaphylaxis treatment market from 2025 to 2034, and what factors influence it?
The market size for anaphylaxis treatment has witnessed robust growth in the past few years. The market, which stands at a value of $6.19 billion in 2024, is expected to inflate to $6.61 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%. The substantial growth during the historic period can be accredited to the rising occurrence of allergic reactions, broader acknowledgment of anaphylaxis, enhanced accessibility of epinephrine auto-injectors, heightened public awareness and education, as well as training of healthcare professionals.

In upcoming years, experts forecast a robust expansion in the anaphylaxis treatment market. This sector is projected to surge to $8.72 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.2%. This rise during the prediction phase can be linked to innovations in biologic therapies, tailored treatment modalities, international food safety initiatives, increased patient influence and support, as well as enhanced emergency medical facilities. The predicting era sees primary trends such as innovation in auto-injectors, employing telemedicine for managing anaphylaxis, advances in allergen immunotherapy, biometric wearable devices for allergen detection, and cooperation in allergy research work.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

How are the latest trends influencing the growth of the anaphylaxis treatment market?
In the anaphylaxis treatment market, a prominent trend is the enhancement in product development. To maintain their market share, leading companies in the anaphylaxis treatment field are progressively improving their products. For instance, in April 2022, Aquestive Therapeutics Inc., an American pharmaceutical firm, was granted Fast Track designation by the Food and Drug Administration for AQST-109, a treatment for severe allergic reactions including anaphylaxis. The company is progressing with clinical trials of AQST-109. This is the first known orally administered epinephrine product candidate that has shown results on par with autoinjectors (like EpiPen and Auvi-Q) in treating allergic crises, including anaphylaxis.

What are the major segments of the anaphylaxis treatment market and their role in driving growth?
The anaphylaxis treatment market covered in this report is segmented -

1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:
1) By Epinephrine: Auto-Injectors, Vials Or Syringes
2) By Antihistamines: Oral Antihistamines, Injectable Antihistamines
3) By Steroids: Oral Steroids, Injectable Steroids
4) By Beta-antagonists: Oral Beta-blockers, Injectable Beta-blockers
5) By Other Treatments: Corticosteroids, Intravenous Fluids, Other Supportive Treatments

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12105

Which regions are key players in the growth of the anaphylaxis treatment market?
North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the anaphylaxis treatment market?
Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

What Is Covered In The Anaphylaxis Treatment Global Market Report?

• Market Size Forecast: Examine the anaphylaxis treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the anaphylaxis treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the anaphylaxis treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the anaphylaxis treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the anaphylaxis treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the anaphylaxis treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the anaphylaxis treatment market.
• Competitive Landscape: Review strategic developments in the anaphylaxis treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.